^
Association details:
Biomarker:EGFR H773delinsYNPY
Cancer:Lung Cancer
Drug:Tagrisso (osimertinib) (EGFR inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: D – Preclinical
New
Title:

Clinical Relevance of Patient-Derived Organoid of Surgically Resected Lung Cancer as an In Vitro Model for Biomarker and Drug Testing

Published date:
07/26/2023
Excerpt:
LTO9 cells harboring EGFR H773delinsYNPY were sensitive to osimertinib.
DOI:
https://doi.org/10.1016/j.jtocrr.2023.100554